Daiichi Sankyo Co., Ltd. (DSKYF)
16.16
+0.16
(+1.00%)
USD |
OTCM |
May 20, 15:07
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 29.41B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -35.45% |
| Valuation | |
| PE Ratio | 17.28 |
| PE Ratio (Forward) | |
| PS Ratio | 2.139 |
| Price to Book Value | 2.811 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.3182 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.1806 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 63.14% |
Profile
| Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded in 2005 and is headquartered in Tokyo, Japan. |
| URL | https://www.daiichisankyo.co.jp |
| Investor Relations URL | https://www.daiichisankyo.com/investors/ |
| HQ State/Province | Tokyo |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Jul. 30, 2026 (est.) |
| Last Earnings Release | May. 11, 2026 |
| Next Ex-Dividend Date | Sep. 30, 2026 |
| Last Ex-Dividend Date | Mar. 31, 2026 |
Profile
| Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded in 2005 and is headquartered in Tokyo, Japan. |
| URL | https://www.daiichisankyo.co.jp |
| Investor Relations URL | https://www.daiichisankyo.com/investors/ |
| HQ State/Province | Tokyo |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Jul. 30, 2026 (est.) |
| Last Earnings Release | May. 11, 2026 |
| Next Ex-Dividend Date | Sep. 30, 2026 |
| Last Ex-Dividend Date | Mar. 31, 2026 |